Jennifer Schneider's Net Worth
$15.4 Million
Who is Jennifer Schneider?
Jennifer Schneider has an estimated net worth of $15.4 Million. This is based on reported shares across multiple companies, which include Revolution Healthcare Acquisition Corp., Livongo Health, Inc., Health Assurance Acquisition Corp., and VERTEX PHARMACEUTICALS INC / MA.
SEC CIK
Jennifer Schneider's CIK is 0001783060
Past Insider Trading and Trends
2020 was Jennifer Schneider's most active year for acquiring shares with 12 total transactions. Jennifer Schneider's most active month to acquire stocks was the month of April. 2020 was Jennifer Schneider's most active year for disposing of shares, totalling 53 transactions. Jennifer Schneider's most active month to dispose stocks was the month of July. 2020 saw Jennifer Schneider paying a total of $106,186.40 for 201,756 shares, this is the most they've acquired in one year. In 2020 Jennifer Schneider cashed out on 1,288,147 shares for a total of $14,864,084.97, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Revolution Healthcare Acquisition Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Livongo Health, Inc. No price found
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -208.39K |
—
|
—
|
0
|
Oct 30
| |||
Form 4
|
—
|
0
|
$62.65 | -$7,454,904.20 | 208.18K |
Scheduled
|
Sep 3
| ||
Form 4
| -3.97% | -8.60K |
$132.53 | -$1,139,492.94 | 208.18K |
Aug 26
| |||
Form 4
|
—
|
0
|
$68.67 | -$1,818,788.69 | 216.33K |
Scheduled
|
Aug 3 - Aug 4
| ||
Form 4
| -0.72% | -1.58K |
$37.55 | -$986,168.35 | 216.33K |
Scheduled
|
Jul 1 - Jul 2
| ||
Form 4
| -2.42% | -5.41K |
$29.71 | -$779,129.85 | 217.91K |
Scheduled
|
Jun 1 - Jun 2
| ||
Form 4
| -2.77% | -6.35K |
$55.00 | -$349,470.00 | 223.31K |
May 26
| |||
Form 4
| +42.51% | 68.51K |
$59.32 | -$30,668.44 | 229.67K |
May 14 - May 15
| |||
Form 4
| -0.32% | -525.00 |
$19.66 | -$505,911.55 | 161.16K |
Scheduled
|
May 1 - May 4
| ||
Form 4
| -0.32% | -517.00 |
$38.50 | -$19,904.50 | 161.69K |
Apr 15
| |||
Form 4
| -14.37% | -27.22K |
$13.94 | -$1,430,170.82 | 162.2K |
Scheduled
|
Apr 1 - Apr 2
| ||
Form 4
| -0.19% | -361.00 |
$20.17 | -$7,281.37 | 189.43K |
Mar 16
| |||
Form 4
| -1.74% | -3.35K |
$25.27 | -$84,705.04 | 189.79K |
Feb 25
| |||
Form 4
| -0.19% | -361.00 |
$26.93 | -$9,721.73 | 193.14K |
Feb 18
| |||
Form 4
| -2.47% | -4.90K |
$28.90 | -$141,581.10 | 193.5K |
Jan 21
| |||
Form 4
| -1.61% | -3.25K |
$27.68 | -$89,932.32 | 198.4K |
Dec 2
| |||
Form 4
| -1.63% | -3.35K |
$31.34 | -$105,020.34 | 201.65K |
Aug 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Health Assurance Acquisition Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $468
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 922 |
—
|
—
| 922 |
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||